Cipla inks investment pact with FIL Capital Investments

Published On 2015-11-29 07:59 GMT | Update On 2015-11-29 07:59 GMT

New Delhi : Cipla today said it has inked an investment agreement with FIL Capital Investments (Mauritius) II Limited for its consumer healthcare business.

"Cipla Health Ltd and FIL Capital Investments (Mauritius) II Limited have on November 27, 2015 signed an investment agreement", Cipla said in a regulatory filing.

The investment is subject to approvals from the Foreign Investment Promotion Board and the Competition Commission of India, and the transfer of Cipla's consumer healthcare business to Cipla Health Ltd, it added.

The company however did not disclose the financial details of the agreement.

In July, Cipla's board had approved an investment by Fidelity Growth Partners India and US-based Fidelity Biosciences, through FIL Capital Investments (Mauritius) II or its affiliates in its recently launched consumer healthcare business.

Through the consumer healthcare business, Cipla has entered the over-the-counter (OTC) healthcare market in India.

Earlier, the Mumbai-based company's board had approved divestment of its consumer healthcare business to Cipla Health, a wholly-owned subsidiary, by way of a slump sale for a consideration of Rs 10.5 crore.

The Indian Consumer Health Care (CHC) is a USD 4 billion market and is growing at a CAGR of 15 per cent. It is expected to be a USD 10 billion market by 2020. MSS ANU

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Meghna A Singhania is the founder and Editor-in-Chief at Medical Dialogues. An Economics graduate from Delhi University and a post graduate from London School of Economics and Political Science, her key research interest lies in health economics, and policy making in health and medical sector in the country. She is a member of the Association of Healthcare Journalists. She can be contacted at meghna@medicaldialogues.in. Contact no. 011-43720751

Comments Policy

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Cipla inks investment pact with FIL Capital Investments

Similar News

India conferred with Bloomberg Philanthropies Global Tobacco Control Award

LIC eyes entry into health insurance space by month end

Meerut doctor, 3 Touts arrested for illegal sex determination test

RG Kar Financial Irregularities Case: Court Reprimands CBI for Failing to Provide Documents

World Leprosy Day 2025: WHO urges Governments to focus on Leprosy elimination

Doctor killed, another injured as car plunges into canal in Ballia

Dera Followers Castration Case: Punjab and Haryana HC Rejects Doctor's Plea to Waive Bail Conditions

Telangana Medical Council warns Public against Illegal Online Lab Tests